A conserved signal-responsive sequence mediates activation-induced alternative splicing of CD45

Molecular Cell

Volumn 12, Issue 5, 2003, Pages 1317-1324

  Rothrock, Caryn ^a   Cannon, Brian ^a   Hahm, Brandon ^a   Lynch, Kristen W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; PHORBOL 13 ACETATE 12 MYRISTATE;

ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; EXON; GENE IDENTIFICATION; GENETIC REGULATION; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MOLECULAR DYNAMICS; MULTIGENE FAMILY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA SEQUENCE; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0345276470     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00434-9     Document Type: Article

References (23)

1. Black D.L. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72:2003;291-336.
2. Caceres J.F., Kornblihtt A.R. Alternative splicing. multiple control mechanisms and involvement in human disease Trends Genet. 18:2002;186-193.
3. Cartegni L., Chew S.L., Krainer A.R. Listening to silence and understanding nonsense. exonic mutations that affect splicing Nat. Rev. Genet. 3:2002;285-298.
4. Chandler D.S., Qi J., Mattox W. Direct repression of splicing by transformer-2. Mol. Cell. Biol. 23:2003;5174-5185.
5. Chang H.L., Lefrancois L., Zaroukian M.H., Esselman W.J. Developmental expression of CD45 alternate exons in murine T cells. Evidence of additional alternate exon use. J. Immunol. 147:1991;1687-1693.
6. Fairbrother W.G., Yeh R.F., Sharp P.A., Burge C.B. Predictive identification of exonic splicing enhancers in human genes. Science. 297:2002;1007-1013.
7. Hermiston M.L., Xu Z., Majeti R., Weiss A. Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases. J. Clin. Invest. 109:2002;9-14.
8. Herrlich P., Zoller M., Pals S.T., Ponta H. CD44 splice variants. metastases meet lymphocytes Immunol. Today. 14:1993;395-399.
9. Jacobsen M., Schweer D., Ziegler A., Gaber R., Schock S., Schwinzer R., Wonigeit K., Lindert R.B., Kantarci O., Hemmer B., et al. A point mutation in PTPRC is associated with the development of multiple sclerosis. Nat. Genet. 26:2000;495-499.
10. Konig H., Ponta H., Herrlich P. Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator. EMBO J. 17:1998;2904-2913.
11. Ladd, A.N., and Cooper, T.A. (2002). Finding signals that regulate alternative splicing in the post-genomic era. Genome Biol. http://genomebiology. com/2002/3/11/reviews/0008 .
12. Lynch K.W., Maniatis T. Assembly of specific SR protein complexes on distinct regulatory elements of the Drosophila doublesex splicing enhancer. Genes Dev. 10:1996;2089-2101.
13. Lynch K.W., Weiss A. A model system for the activation-induced alternative-splicing of CD45 implicates protein kinase C and Ras. Mol. Cell. Biol. 20:2000;70-80.
14. Lynch K.W., Weiss A. A CD45 polymorphism associated with multiple sclerosis disrupts an exonic splicing silencer. J. Biol. Chem. 276:2001;24341-24347.
15. Magistrelli G., Jeannin P., Herbault N., Benoit De Coignac A., Gauchat J.F., Bonnefoy J.Y., Delneste Y. A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells. Eur. J. Immunol. 29:1999;3596-3602.
16. Oaks M.K., Hallett K.M., Penwell R.T., Stauber E.C., Warren S.J., Tector A.J. A native soluble form of CTLA-4. Cell. Immunol. 201:2000;144-153.
17. Smale S.T., Fisher A.G. Chromatin structure and gene regulation in the immune system. Annu. Rev. Immunol. 20:2002;427-462.
18. Smith M.A., Fanger G.R., O'Connor L.T., Bridle P., Maue R.A. Selective regulation of agrin mRNA induction and alternative splicing in PC12 cells by Ras-dependent actions of nerve growth factor. J. Biol. Chem. 272:1997;15675-15681.
19. Stamm S. Signals and their transduction pathways regulating alternative splicing. a new dimension of the human genome Hum. Mol. Genet. 11:2002;2409-2416.
20. Trowbridge I.S., Thomas M.L. CD45. an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development Annu. Rev. Immunol. 12:1994;85-116.
21. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., Rainbow D.B., Hunter K.M., Smith A.N., DiGenova G., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 423:2003;506-511.
22. Xie J., Black D.L. A CaMK IV responsive RNA element mediates depolarization-induced alternative splicing of ion channels. Nature. 410:2001;936-939.
23. Xu Z., Weiss A. Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nat. Immunol. 3:2002;764-771.